Steiner

VERU ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Veru Inc. and Encourages Investors to Contact the Firm

Retrieved on: 
Wednesday, December 7, 2022
Class Action Lawsuit, Professional Services, Legal, Fast Track, P.C, Standard of care, Acute respiratory distress syndrome, Aerospace, Tiberius Claudius Verus, Person, NDA, Health minister, Jeanne Eagels, Court, Patient, Death, FDA, Fast track (FDA), Form 10-Q, COVID-19, News, Trial of the century, Steiner, Breast, Safety, Telephone, EUA, Mortality, Prostate cancer, Infection, Prostate Cancer Foundation, Pharmaceutical industry, Renewable energy

Investors have until February 3, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until February 3, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • Veru is primarily an oncology-based biopharmaceutical company that develops drugs for the management of breast and prostate cancers.
  • Veru had originally developed sabizabulin with the intention of using it as a treatment for prostate cancer.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

Engrain Announces New Map Views in SightMap

Retrieved on: 
Thursday, November 3, 2022
CEO, Map, Research, Data visualization, Technology, Steiner, Restaurant, Asset (intelligence), Renting, Online shopping

DENVER, Nov. 3, 2022 /PRNewswire/ -- Engrain, the market leader in interactive touring, mapping and data visualization software for the multifamily industry, today announced the release of street map and satellite map views within SightMap, multifamily's leading interactive map tool. The new homefront search feature allows renters to toggle between multiple map views and expands context beyond a community and into the surrounding neighborhood.

Key Points: 
  • DENVER, Nov. 3, 2022 /PRNewswire/ -- Engrain , the market leader in interactive touring, mapping and data visualization software for the multifamily industry, today announced the release of street map and satellite map views within SightMap, multifamily's leading interactive map tool.
  • The new homefront search feature allows renters to toggle between multiple map views and expands context beyond a community and into the surrounding neighborhood.
  • "This major release moves SightMap even closer to a more traditional map search experience, something we've been working closely on for a while," said Brent Steiner, founder and CEO of Engrain.
  • The new search views on SightMap create an experience closer to a traditional map search and provide a more streamlined approach to cross-property searches.

Grants Plus Appoints Dana Textoris CEO and Celebrates Over $250 Million Raised for Nonprofit Sector

Retrieved on: 
Thursday, September 29, 2022
American Psychological Association, FBE, Time, COVID-19, Woman, Commission to Study the Potential Creation of a National Women's History Museum, LinkedIn, Award, Partnership, City, CEO, National, Steiner, Chief services officer, Housing, National Center for Construction Education and Research, Cincinnati metropolitan area, National Center for Healthy Housing, Management, Pharmaceutical industry, Public relations, Jean Boniface Textoris

CLEVELAND, Sept. 29, 2022 /PRNewswire-PRWeb/ -- Grants Plus announces today that Dana Textoris has been named CEO of Grants Plus. The appointment comes as the firm marks its 15th year in business serving nonprofits and ahead of National Women's Small Business Month in October.

Key Points: 
  • National Fundraising Firm Names Leader Ahead of October National Women's Small Business Month, Celebrates $250 Million Raised for Nonprofit Sector
    CLEVELAND, Sept. 29, 2022 /PRNewswire-PRWeb/ -- Grants Plus announces today that Dana Textoris has been named CEO of Grants Plus.
  • Textoris has worked alongside the founder and owner of Grants Plus, Lauren Steiner, for nearly 10 years.
  • In her time at Grants Plus, Textoris has led growth strategies for the firm, expanding its nonprofit client base and employee workforce to a national scale.
  • "Dana is the powerhouse that drove our national expansion over the past 10 years," says Lauren Steiner, Founder and Owner of Grants Plus.

Columbia Business School's Deming Center Awards 2022 Deming Cup to Tim Steiner and Kathy Warden

Retrieved on: 
Tuesday, September 6, 2022
School of International and Public Affairs, Columbia University, Quality, Best Buy, Janet DiFiore, Technology, CEO, Chenault, Columbia Business School, Macy's, Inc., Research, Marriott International, Northwell Health, Competition (economics), Solution, Ocado Group, Culture, Intermountain, Memorial Sloan Kettering Cancer Center, Fiat Chrysler Automobiles, General Motors, American Express, Curriculum, B-21, Organization, Student, Multimedia, Northrop, Operational excellence, PepsiCo, News, Steiner, S. C. Johnson & Son, Intermountain Healthcare, Johns Hopkins Hospital, Growth, IBM, Grumman, James Webb Space Telescope, Industry, Deming, New, UPS, Management, Dredging, Ecolab, Merck, Northrop Grumman

NEW YORK, Sept. 6, 2022 /PRNewswire/ -- Columbia Business School's W. Edwards Deming Center for Quality, Productivity, and Competitiveness announced Tim Steiner, CEO and co-founder of Ocado Group, and Kathy Warden, chair, CEO and president of Northrop Grumman, will receive its 2022 Deming Cup for Operational Excellence Award at a ceremony in Columbia University's Low Library Rotunda on October 25.

Key Points: 
  • NEW YORK, Sept. 6, 2022 /PRNewswire/ -- Columbia Business School's W. Edwards Deming Center for Quality, Productivity, and Competitiveness announced Tim Steiner, CEO and co-founder of Ocado Group, and Kathy Warden, chair, CEO and president of Northrop Grumman, will receive its 2022 Deming Cup for Operational Excellence Award at a ceremony in Columbia University's Low Library Rotunda on October 25.
  • Since 2010, the Deming Cup has recognized leaders for operational excellence and fostering a culture of continuous improvement within their organizations.
  • In his congratulations to Steiner and Warden, Professor Nelson Fraiman , director of the Deming Center, applauded them for "exemplifying the Deming principles in leading breakthrough solutions within their industries."
  • On receiving news of the award, Tim Steiner said: "I am delighted to receive the Deming Cup.

Bipolar Winter, Volume I: A Work of Fiction Based on Historical Facts

Retrieved on: 
Monday, August 1, 2022
Catholic Church, Life, Adult, Spirituality, Steiner, Religion, Anti-Catholicism, Adventism, Book, St. Mary's Church, Pontifical Gregorian University, Coffee, Bipolar, Amazon

PETALUMA, Calif., Aug. 1, 2022 /PRNewswire/ -- Bipolar Winter, Volume I is author Samuel David Steiner's novel based on historical facts surrounding the Seventh-day Adventist church.

Key Points: 
  • PETALUMA, Calif., Aug. 1, 2022 /PRNewswire/ -- Bipolar Winter, Volume I is author Samuel David Steiner's novel based on historical facts surrounding the Seventh-day Adventist church.
  • Bipolar Winter, Volume I introduces readers to historian Aldo Lombardi, a recent graduate of the Pontifical Gregorian University summoned to appear before Pope Benedict.
  • Steiner, a native of Mobile, Alabama, began the Bipolar Winter project in 2011, and Bipolar Winter, Volume I was published in July 2020.
  • For more information on the Bipolar Winter project and to preview the prologue and chapter 1 of Bipolar Winter, Volume I, visit https://www.bipolarwinter.com/ .

Renowned Real Estate Technology Leader Steiner Jovanovic Joins LeaseLock Board of Directors

Retrieved on: 
Tuesday, July 19, 2022
Leadership, Housing, Croisière du Grand Hiver, NMHC, Solution, Steiner, Property, AI, Insurance, Growth, EVP, Risk assessment, PGIM, Risk management, Liberty Mutual, Development, Industry, LOS, Risk, RealPage, Goldman Sachs, Financial services, Property management, Greystar Real Estate Partners

LOS ANGELES, July 19, 2022 /PRNewswire/ -- LeaseLock, the world's leading insurtech platform for real estate, announces the addition of Janine Steiner Jovanovic, principal at JSJ Advisors and former EVP of Asset Optimization at RealPage, to the LeaseLock Board of Directors. Jovanovic's expertise will help guide the financial technology company as they modernize the way the multifamily industry manages risk and protects against loss.

Key Points: 
  • "Janine is a titan in the multifamily community, and we're incredibly privileged to attach her experience and leadership to the LeaseLock Board of Directors," said Ed Wolff, Chief Revenue Officer of LeaseLock.
  • Building on the momentum created by LeaseLock's lease insurance, Steiner Jovanovic will help shape the company's expanding product suite.
  • Steiner joins several other esteemed colleagues on the LeaseLock Board of Directors.
  • LeaseLock financial performance technology is driving the next revolution in residential real estate.

Teva Announces Promising Interim Results From Its Study PEARL, About the Impact of AJOVY® (fremanezumab)

Retrieved on: 
Friday, June 24, 2022
Biotechnology, Neurology, Health, Pharmaceutical, Clinical Trials, Review, Annual report, Migraine, PEARL, International Classification of Headache Disorders, Teva Pharmaceuticals, Headache, International Headache Society, IHS, Travel, Biosimilar, COVID-19, Failure, Health care, TASE, Silberstein, Pain, TEVA, Compliance, Cephalalgia, Knowledge Organization (journal), Woman, Teva, Investment, KPMG, Steiner, EU, Private Securities Litigation Reform Act, NYSE, Real, Observational study, Pain management, Forward-looking statement, Pharmaceutical industry, Silviculture, Aroma compound, Lipton, Ashina

AJOVY is available as a 225 mg/1.5 mL single dose injection in a pre-filled syringe or, in some countries, in a pre-filled pen.

Key Points: 
  • AJOVY is available as a 225 mg/1.5 mL single dose injection in a pre-filled syringe or, in some countries, in a pre-filled pen.
  • AJOVY can be administered either by a healthcare professional or at home by a patient or caregiver.
  • Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has been developing and producing medicines to improve peoples lives for more than a century.
  • (v0.1) - The two year Pan-European Real World (PEARL) prospective, observational study of AJOVY (fremanezumab)
    2 KPMG, prepared for the European Migraine and Headache Alliance (EMHA).

Lundbeck to Present Data on VYEPTI® (eptinezumab-jjmr) at the 64th Annual Scientific Meeting of the American Headache Society, Furthering Clinical and Real-World Evidence for Migraine Prevention

Retrieved on: 
Thursday, June 9, 2022
Health, Other Health, Clinical Trials, Research, Science, Pharmaceutical, Biotechnology, Diamond, Woman, Eptinezumab, Neurological disorder, Caregiver, Headache, AHS, Research, Marketing, Lists of diseases, Nausea, Amitriptyline, Disease, Headache (journal), MHD, Steiner, Global Burden of Disease Study, Migraine, Failure, WPAI, CGRP, Disability, Patient, YLD, VAS, Calcitonin gene-related peptide, Topiramate, MSQ, Poster, LUN, Vomiting, Birth control, Pharmaceutical industry, Medical imaging, Aroma compound, Lundbeck, Virtual Private LAN Service

Lundbeck today announced data on VYEPTI (eptinezumab-jjmr) will be presented at the 64th Annual Scientific Meeting of the American Headache Society (AHS) taking place from June 9-12, 2022.

Key Points: 
  • Lundbeck today announced data on VYEPTI (eptinezumab-jjmr) will be presented at the 64th Annual Scientific Meeting of the American Headache Society (AHS) taking place from June 9-12, 2022.
  • A total of nine poster presentations will be shared to highlight clinical data and real-world analyses of eptinezumab as a preventive migraine treatment in adults.
  • These data continue to show the clinical benefit of VYEPTI as a preventive treatment option for people with migraine, said Marija Geertsen, M.D., Vice President, U.S. Medical Affairs, Lundbeck.
  • The safety of VYEPTI was evaluated in 2,076 patients with migraine who received at least one dose of VYEPTI.

UPDATE: WellSpan York Hospital launches Aidoc’s innovative AI solution to aid radiologists in flagging abnormalities in scans

Retrieved on: 
Tuesday, March 22, 2022
Self-signed certificate, Diagnosis, WellSpan Health, Hospital, Centre County, Pennsylvania, Intelligence, Embolism, Radiology, Omicron, Review, Stroke, Radiation therapy, COVID-19, GLOBE, Steiner, Fellow, Trauma, Eye, AI, Patient, Medical imaging, Aidoc

York, Pa., March 22, 2022 (GLOBE NEWSWIRE) -- WellSpan Health today announces implementation of Aidocs innovative solution that it is putting the power of artificial intelligence to work in WellSpan York Hospital.

Key Points: 
  • York, Pa., March 22, 2022 (GLOBE NEWSWIRE) -- WellSpan Health today announces implementation of Aidocs innovative solution that it is putting the power of artificial intelligence to work in WellSpan York Hospital.
  • Aidocs solution was launched at WellSpan York Hospital on Feb. 22 and not only flags abnormalities but also prioritizes these urgent findings for radiologists to review.
  • Aidocs always-on AI solution constantly studies all scans and suggests prioritization, notifying the findings within two to six minutes directly in the physicians workflow.
  • WellSpan York Hospital performs 580,000 scans per year and has one of the largest emergency departments in the region.

WellSpan York Hospital launches Aidoc’s innovative AI solution to aid radiologists in flagging abnormalities in scans

Retrieved on: 
Tuesday, March 22, 2022
Self-signed certificate, Diagnosis, WellSpan Health, Hospital, Centre County, Pennsylvania, Intelligence, Embolism, Radiology, Omicron, Review, Stroke, Radiation therapy, COVID-19, GLOBE, Steiner, Fellow, Trauma, Eye, AI, Patient, Medical imaging, Aidoc

York, Pa., March 22, 2022 (GLOBE NEWSWIRE) -- WellSpan Health today announces implementation of Aidocs innovative solution that it is putting the power of artificial intelligence to work in WellSpan York Hospital.

Key Points: 
  • York, Pa., March 22, 2022 (GLOBE NEWSWIRE) -- WellSpan Health today announces implementation of Aidocs innovative solution that it is putting the power of artificial intelligence to work in WellSpan York Hospital.
  • Aidocs solution was launched at WellSpan York Hospital on Feb. 22 and not only flags abnormalities but also prioritizes these urgent findings for radiologists to review.
  • Aidocs always-on AI solution constantly studies all scans and suggests prioritization, notifying the findings within two to six minutes directly in the physicians workflow.
  • WellSpan York Hospital performs 580,000 scans per year and has one of the largest emergency departments in the region.